Company news
UroGen Pharma Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
November 10, 2019
UroGen Pharma to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
November 5, 2019
UroGen Reports Positive Data from Two Important Studies: UGN-101 OLYMPUS Pivotal Trial in LG UTUC and UGN-102 Phase 2b OPTIMA II Trial in LG Bladder Cancer
September 23, 2019
UroGen To Host Investor Day on September 24, 2019 Spotlighting Clinical Development Updates and UGN-101 Launch Readiness
September 9, 2019
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Urogen Pharma (NASDAQ:URGN) Q2 2026 Earnings Call
Aug 5, 2026
Transcript - Urogen Pharma (NASDAQ:URGN) Q1 2026 Earnings Call
May 6, 2026
Transcript - Urogen Pharma (NASDAQ:URGN) Q4 2025 Earnings Call
Mar 2, 2026
Transcript - Urogen Pharma (NASDAQ:URGN) Q2 2025 Earnings Call
Aug 7, 2025
Transcript - Urogen Pharma (NASDAQ:URGN) Q1 2025 Earnings Call
May 12, 2025
Transcript
Decks
The 5 newest of 10 decks. Every deck is listed under its year.
- Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026
- Investor Presentation (January 2025)
Investor deck · 44 slides · Jan 14, 2025
- Technical Presentation (June 2024)
Technical · 57 slides · Jun 13, 2024
- Investor Presentation (March 2024)
Investor deck · 56 slides · Mar 4, 2024
- Investor Presentation (February 2024)
Investor deck · 53 slides · Feb 7, 2024